| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1550169 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASRGL1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ASRGL1 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ASRGL1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:708526 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ASRGL1 mRNA | CTD | PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550169 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ASRGL1 mRNA | CTD | PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ASRGL1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1550169 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ASRGL1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:708526 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ASRGL1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1550169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ASRGL1 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550169 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASRGL1 mRNA | CTD | PMID:17942748 |
| ammonium chloride | affects expression | ISO | RGD:708526 | 6480464 | Ammonium Chloride affects the expression of ASRGL1 mRNA | CTD | PMID:16483693 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of ASRGL1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ASRGL1 mRNA | CTD | PMID:21592394 |
| choline | multiple interactions | ISO | RGD:1550169 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASRGL1 mRNA | CTD | PMID:20938992 |
| clofibric acid | multiple interactions | ISO | RGD:708526 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ASRGL1 mRNA | CTD | PMID:17602206 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ASRGL1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ASRGL1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ASRGL1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ASRGL1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1550169 | 6480464 | Cyclosporine results in increased expression of ASRGL1 mRNA | CTD | PMID:19770486 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of ASRGL1 mRNA | CTD | PMID:19371625 |
| folic acid | multiple interactions | ISO | RGD:1550169 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASRGL1 mRNA | CTD | PMID:20938992 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of ASRGL1 mRNA | CTD | PMID:19371625 |
| L-methionine | multiple interactions | ISO | RGD:1550169 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASRGL1 mRNA | CTD | PMID:20938992 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:708526 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ASRGL1 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:708526 | 6480464 | Diethylnitrosamine results in decreased expression of ASRGL1 mRNA | CTD | PMID:19638242 |
| pirinixic acid | increases expression | ISO | RGD:1550169 | 6480464 | pirinixic acid results in increased expression of ASRGL1 mRNA | CTD | PMID:20813756 |
| progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ASRGL1 mRNA | CTD | PMID:17404688 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ASRGL1 mRNA | CTD | PMID:21632981 |
| rotenone | increases expression | ISO | RGD:708526 | 6480464 | Rotenone results in increased expression of ASRGL1 mRNA | CTD | PMID:19013527 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of ASRGL1 mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of ASRGL1 mRNA | CTD | PMID:21592394 |
| zearalenone | increases expression | EXP | | 6480464 | Zearalenone results in increased expression of ASRGL1 mRNA | CTD | PMID:19371625 |